Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Canellos

Showing results (191-200 of 315) with videos related to

Pageof 32
Sort By:
Haematologica|July 1, 1991
Hodgkin's disease: controversies and challenges for the futureS Tura, G Canellos, A Goldstone, et al.
National Cancer Institute Monograph|May 1, 1973
Intensive chemotherapy for Hodgkin's disease: long-term complicationsV T DeVita, J C Arseneau, R J Sherins, et al.
Cancer Treatment Reports|December 1, 1985
Role of 99mTc methylene diphosphonate bone imaging in the management of lymphomaK C Anderson, W D Kaplan, R C Leonard, et al.
American Journal of Clinical Oncology|June 11, 1999
Phase II trial of topotecan in advanced breast cancer: a Cancer and Leukemia Group B studyE G Levine, C T Cirrincione, T P Szatrowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomasP Mauch, R Leonard, A Skarin, et al.
Cancer|May 15, 1981
Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimenJ M Kirkwood, G P Canellos, T J Ervin, et al.
Lancet (London, England)|February 1, 1975
Advanced diffuse histiocytic lymphoma, a potentially curable diseaseV T DeVita, G P Canellos, B Chabner, et al.
Cancer Treatment Reports|May 1, 1979
Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analogR H Blum, M B Garnick, M Israel, et al.
Leukemia & Lymphoma|May 10, 2007
High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351Bruce A Peterson, Jeffrey Johnson, Margaret A Shipp, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Results of combination chemotherapy of non-Hodgkin's lymphomaP S Schein, B A Chabner, G P Canellos, et al.
Pageof 32

Showing results (191-200 of 315) with videos related to

Sort By:
Pageof 32
Haematologica|July 1, 1991
Hodgkin's disease: controversies and challenges for the futureS Tura, G Canellos, A Goldstone, et al.
National Cancer Institute Monograph|May 1, 1973
Intensive chemotherapy for Hodgkin's disease: long-term complicationsV T DeVita, J C Arseneau, R J Sherins, et al.
Cancer Treatment Reports|December 1, 1985
Role of 99mTc methylene diphosphonate bone imaging in the management of lymphomaK C Anderson, W D Kaplan, R C Leonard, et al.
American Journal of Clinical Oncology|June 11, 1999
Phase II trial of topotecan in advanced breast cancer: a Cancer and Leukemia Group B studyE G Levine, C T Cirrincione, T P Szatrowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomasP Mauch, R Leonard, A Skarin, et al.
Cancer|May 15, 1981
Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimenJ M Kirkwood, G P Canellos, T J Ervin, et al.
Lancet (London, England)|February 1, 1975
Advanced diffuse histiocytic lymphoma, a potentially curable diseaseV T DeVita, G P Canellos, B Chabner, et al.
Cancer Treatment Reports|May 1, 1979
Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analogR H Blum, M B Garnick, M Israel, et al.
Leukemia & Lymphoma|May 10, 2007
High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351Bruce A Peterson, Jeffrey Johnson, Margaret A Shipp, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Results of combination chemotherapy of non-Hodgkin's lymphomaP S Schein, B A Chabner, G P Canellos, et al.
Pageof 32